- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02552004
Assessment of Intraoperative Probe-based Confocal Laser Endomicroscopy in Digestive and Endocrine Surgery: a Pilot Study (Pilot pCLE)
Assessment of the Intraoperative Probe-based Confocal Laser Endomicroscopy in Digestive and Endocrine Surgery - a Pilot Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Intraoperative histological examination is a fundamental tool for cancer surgery (extent of surgery, resection margins, sentinel lymph node) and necessary in other circumstances like redo surgery or endocrine surgery. Using conventional frozen section technique results in the prolongation of operating time of about 40 minutes.
Probe-based Confocal Laser Endomicroscopy (pCLE) is a new imaging technique which enables real-time, microscope-resolution imaging. Specifically, after intravenous injection of a fluorescent contrast agent - in this study fluorescein will be used, the pCLE system provides video sequences of the tissue, using a confocal microscope integrated in a miniprobe and a low power laser as the illumination source (Cellvizio®, Mauna Kea Technologies, Paris, France).
The pCLE is currently used in endoscopy, mainly for the follow-up of Barrett's esophagus, colorectal polyps and strictures of the bile and pancreatic ducts, but also in urology. The pCLE has never been tested in open or video-assisted surgery settings. Sterilizable probes exist and are certified for use via an endoscope in France (UHD CystoFlexTM, AQ-FLEX 19TM Mauna Kea Technologies, Paris, France). A probe (CelioFlex UHDTM) is currently being developed for use in laparoscopic surgery setting.
This pilot study aims to evaluate pCLE in surgical setting. Each anatomical structure corresponds to a specific tissue architecture, which is today known through standard histological examination. Conventional histology implies alteration of the tissue architecture, with ablation of blood supply, sampling and technical treatment of the samples (fixation, cutting, staining). The pCLE enables to bypass this process and allows obtaining images of the microscopic structure in vivo, without cell damage and without interruption of the blood and lymphatic circulation. The obtained video sequences reflect the microscopic architecture, in a form which is to date, neither mapped nor exploited for deep organs. The potential of this technique was demonstrated in intraabdominal organs only in the animal model, with very encouraging results as the sensitivity and specificity of pCLE were superior to standard histological examination.
The primary objective is the depiction of histological rendering of normal and pathological tissues through pCLE. Feasibility of real-time diagnosis will also be assessed. All surgical conditions usually necessitating frozen section will be investigated. A total of 30 patients, with various pathology of the thyroid / parathyroid, stomach, esophagus, pancreas, adrenal, colon / small intestine, liver will be included.
The installation and surgical opening will be performed according to standard protocols. A contrast agent, fluorescein, will be injected intravenously to allow tissue visualization with the pCLE. During the surgery, the surgeon will perform the pCLE examination, to obtain and record video sequences of in situ structures. Frozen sections will be obtained on the same samples and will further guide the surgical decision-making.
Diagnostic criteria will be defined by a surgeon - pathologist team and further validated by retrospective analysis of the sequences in comparison to conventional histology slides. The data will be used to create an image bank of reference optical biopsy images.
The study will allow to point out the surgical conditions in which pCLE is the most effective and reliable and could eventually replace the frozen section technique.
A second study, in comparative prospective settings, could further be focused only on the promising conditions in order to evaluate diagnosis accuracy on a statistical basis.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Strasbourg, France, 67000
- Service de Chirurgie Digestive et Endocrinienne - Nouvel Hôpital Civil
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patient, male or female, over 18 years old
- Patient candidate to digestive or endocrine surgery in whom the surgeon deems necessary intraoperative frozen section
- Patient able to understand the study and to provide informed consent
- Patient affiliated to the French social security system
Exclusion Criteria:
- Patient unable to provide informed consent
- Patient with known or suspected allergy to fluorescein
- Patient who had a previous life-threatening reaction during an angiography
- Patient with a history of multiple and severe allergic reactions to medications
- Patient taking a beta-blocker treatment
- Patient with comorbidity considered by the investigator, as incompatible with the procedures of the study
- Patient pregnant or breastfeeding
- Patient in exclusion period (determined by a previous study or in progress)
- Patient having forfeited their freedom of an administrative or legal obligation
- Patient under guardianship
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: pCLE
Patients subject to endocrine or digestive surgery will have intraoperative pCLE examination.
The installation and surgical opening will be performed according to standard protocols.
The contrast agent, fluorescein, will be injected intravenously to allow tissue visualization with pCLE.
During the surgery, the surgeon will perform the pCLE examination, to obtain and record video sequences of in situ structures.
Frozen sections will be obtained on the same samples and will further guide the surgical decision-making.
|
Histological examination by pCLE technique preceding the frozen section
IV Fluorescein (fluorescent contrast agent) administration
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Diagnosis accuracy of intraoperative imaging with pCLE technique
Time Frame: During surgery
|
The diagnosis proposed by the surgeon / investigator in intraoperative setting on the basis of video sequences of pCLE will be compared to frozen section.
|
During surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Diagnosis accuracy of pCLE imaging, retrospectively using the newly described diagnosis criteria
Time Frame: One year
|
The diagnosis proposed by the surgeon / investigator after retrospective review of the intraoperative video sequences of pCLE based on the newly described diagnosis criteria will be compared to frozen section and conventional histology.
|
One year
|
|
pCLE video sequences interpretation learning curve
Time Frame: One year
|
Comparison of the surgeon's ability to obtain intraoperative diagnosis relative to that of the pathologist in the same circumstances.
|
One year
|
|
Time needed for pCLE imaging procedure
Time Frame: During surgery
|
Evaluation of the time required for the practice of pCLE and comparison to the time required for frozen section.
|
During surgery
|
|
Specific morbidity and mortality rate
Time Frame: One month after surgery
|
Morbidity rate / mortality specific to the pCLE imaging procedure.
|
One month after surgery
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Mihaela Ignat, MD, PhD, Service de Chirurgie Digestive et Endocrinienne - Nouvel Hôpital Civil - Strasbourg
Publications and helpful links
General Publications
- Wallace MB, Fockens P. Probe-based confocal laser endomicroscopy. Gastroenterology. 2009 May;136(5):1509-13. doi: 10.1053/j.gastro.2009.03.034. Epub 2009 Mar 28. No abstract available.
- Ignat M, Aprahamian M, Lindner V, Altmeyer A, Perretta S, Dallemagne B, Mutter D, Marescaux J. Feasibility and reliability of pancreatic cancer staging using fiberoptic confocal fluorescence microscopy in rats. Gastroenterology. 2009 Nov;137(5):1584-92.e1. doi: 10.1053/j.gastro.2009.07.045. Epub 2009 Jul 24.
- Kwan AS, Barry C, McAllister IL, Constable I. Fluorescein angiography and adverse drug reactions revisited: the Lions Eye experience. Clin Exp Ophthalmol. 2006 Jan-Feb;34(1):33-8. doi: 10.1111/j.1442-9071.2006.01136.x.
- Ignat M, Lindner V, Vix M, Marescaux J, Mutter D. Intraoperative Probe-Based Confocal Endomicroscopy to Histologically Differentiate Thyroid From Parathyroid Tissue Before Resection. Surg Innov. 2019 Apr;26(2):141-148. doi: 10.1177/1553350618814078. Epub 2018 Nov 23.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 15-001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Malignant Tumor
-
Elpiscience Biopharma, Ltd.Shanghai Junshi Bioscience Co., Ltd.CompletedNeoplasms | Solid Tumor | Malignant TumorChina
-
Sixth Affiliated Hospital, Sun Yat-sen UniversityCompletedLocal Recurrence of Malignant Tumor of Rectum | Local Re-Recurrence of Malignant Tumor of Rectum
-
Daiichi SankyoMerck Sharp & Dohme LLCRecruitingAdvanced Solid Tumor | Malignant Solid TumorUnited States, Japan
-
First Hospital of China Medical UniversityRecruiting
-
Peking Union Medical College HospitalRecruiting
-
Capital Medical UniversityCompleted
-
Capital Medical UniversityCompleted
-
Asclepius Technology Company Group (Suzhou) Co....UnknownMalignant TumorChina
-
Seoul National University HospitalUnknown
-
University Hospitals Cleveland Medical CenterApollo Endosurgery, Inc.CompletedColon Malignant Tumor | Colon Benign TumorUnited States
Clinical Trials on pCLE
-
Huazhong University of Science and TechnologyRecruitingEarly Gastric Cancer | Low Grade Intraepithelial Neoplasia | High Grade Intraepithelial Neoplasia | Gastric Intraepithelial NeoplasiaChina
-
King Chulalongkorn Memorial HospitalCompleted
-
Mauna Kea TechnologiesCompletedLung Neoplasms | Disorder Related to Lung TransplantationUnited States
-
Mauna Kea TechnologiesEmissary International LLC; Cellvizio Inc.CompletedAdenocarcinoma | Barrett's Esophagus | Barrett Esophagus | Barrett Syndrome | Barrett's SyndromeUnited States, France, Germany
-
Virendra JoshiCompleted
-
Yonsei UniversityUnknownAdvanced Gastric Cancer | Neoadjuvant Chemotherapy | Palliative ChemotherapyKorea, Republic of
-
Mauna Kea TechnologiesCellvizio Inc.CompletedAdenocarcinoma | Barrett's Esophagus | Barrett Esophagus | Barrett Syndrome | Barrett's SyndromeUnited States, United Kingdom, France
-
University of Colorado, DenverNorthwell Health; University of Pittsburgh; Weill Medical College of Cornell... and other collaboratorsCompletedPrimary Sclerosing CholangitisUnited States
-
Karolinska University HospitalKarolinska InstitutetCompletedBenign Neoplasm of Liver and/or Biliary Ducts | Neoplasm of Uncertain Behavior of Biliary System | Benign Neoplasms of the Pancreas | Neoplasms of the PancreasSweden
-
Shandong UniversityUnknownGastric Intestinal Metaplasia | Confocal Laser Endomicroscopy | Biopsy | Operative Link on Gastric Intestinal MetaplasiaChina